VESALIUS-CV was big in 2025, but studies looking at triglycerides, CRISPR, and oral GLP-1s also made the highlight reel.
Assessments used to calculate cardiovascular disease risk in the general population may not have the same predictive power ...
There is increasing evidence that gum disease is associated with increased risk of cardiovascular events, including heart ...
Medindia on MSN
Bleeding gums may raise your heart attack risk
Researchers describe several biological pathways linking oral disease to heart disease. Bacteria from inflamed gums may enter the bloodstream and contribute to vascular injury. In addition, persistent ...
The FDA approved Lerochol, a monthly PCSK9 inhibitor, for adults with hypercholesterolemia to reduce LDL-C levels alongside diet and exercise.
A review by the American Heart Association Cardiovascular Disease Prevention Committee strengthens the case that keeping our ...
India carries a heavy cardiometabolic burden of nearly 30%, intensified by early-onset diabetes, hypertension, dyslipidaemia, ...
The drug was as good as a proven GLP-1, giving doctors another potent option for patients with type 2 diabetes and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback